Natural and vaccine-induced acquisition of cross-reactive IgG inhibiting ICAM-1-specific binding of a PfEMP1 subtype associated specifically with cerebral malaria

Simple item page
dc.contributor.authorOlsen, R.W.
dc.contributor.authorEcklu-Mensah, G.
dc.contributor.authorBengtsson, A.
dc.contributor.authorOfori, M.F.
dc.contributor.authorLusingu, J.P.A.
dc.contributor.authorCastberg, F.C.
dc.contributor.authorHviid, L.
dc.contributor.authorAdams, Y.
dc.contributor.authorJensen, A.T.R.
dc.date.accessioned2019-07-09T08:56:16Z
dc.date.available2019-07-09T08:56:16Z
dc.date.issued2018-02
dc.description.abstractCerebral malaria (CM) is a potentially deadly outcome of Plasmodium falciparum malaria that is precipitated by sequestration of infected erythrocytes (IEs) in the brain. The adhesion of IEs to brain endothelial cells is mediated by a subtype of parasite-encoded PfEMP1 that facilitate dual binding to host ICAM-1 and EPCR. The PfEMP1 subtype is characterized by the presence of a particular motif (DBLβ_motif) in the constituent ICAM-1-binding DBLβ domain. The rate of natural acquisition of DBLβ_motif-specific IgG and the ability to induce such antibodies by vaccination are unknown, and the aim of this study was to provide such data. We used ELISA to measure DBLβ-specific IgG in plasma from Ghanaian children with malaria. The ability of human immune plasma and DBLβ-specific rat anti-sera to inhibit the interaction between ICAM-1 and DBLβ was assessed using ELISA and in vitro assays of IE adhesion under flow. Acquisition of DBLβ_motif-specific IgG coincided with age-specific susceptibility to CM. Broadly cross-reactive antibodies inhibiting the interaction between ICAM-1 and DBLβ_motif domains were detectable in immune plasma and in sera of rats immunized with specific DBLβ_motif antigens. Importantly, antibodies against the DBLβ_motif inhibited ICAM-1-specific in vitro adhesion of erythrocytes infected by four of five P. falciparum isolates from cerebral malaria patients. We conclude that natural exposure to P. falciparum as well as immunization with specific DBLβ_motif antigens can induce cross-reactive antibodies that inhibit the interaction between ICAM-1 and a broad range of DBLβ_motif domains. These findings raise hope that a vaccine designed specifically to prevent CM is feasible.en_US
dc.identifier.otherDOI: 10.1128/IAI.00622-17
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/31324
dc.language.isoenen_US
dc.publisherInfection and Immunityen_US
dc.subjectDBLβ cross-reactive antibodiesen_US
dc.subjectICAM-1-binding motifen_US
dc.subjectPfEMP1en_US
dc.subjectPlasmodium falciparumen_US
dc.subjectAdhesion inhibitionen_US
dc.titleNatural and vaccine-induced acquisition of cross-reactive IgG inhibiting ICAM-1-specific binding of a PfEMP1 subtype associated specifically with cerebral malariaen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Natural and vaccine-induced acquisition of cross-reactive IgG inhibiting ICAM-1-specific binding of a PfEMP1 subtype associated specifically with cerebral malaria.pdf
Size:
1.56 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Immunology Department